IP Library Granted Patent US 8,114,977
Granted Patent B2
US 8,114,977 · App. 12/819,033 · Granted Feb 14, 2012

Proteins derived from white spot syndrome virus and uses thereof

Assignee: Intervet International B.V.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,114,977
App. No.
12/819,033
Granted
Feb 14, 2012
Kind
B2
Abstract

Embodiments of the present invention generally relate to proteins derived from white spot syndrome virus, nucleic acid sequences encoding them, and their use in the manufacture of a vaccine for prophylaxis and/or treatment of white spot syndrome in crustaceans.

Claims (5)

1. An isolated nucleic acid encoding only a White Spot Syndrome virus envelope protein having the amino acid sequence of SEQ ID NO.: 4.

2. The nucleic acid of claim 1 , wherein the nucleic acid is SEQ ID NO.:2.

3. A non-White Spot Syndrome virus vector comprising the nucleic acid of claim 2 .

4. A pharmaceutical composition comprising the nucleic acid of claim 1 and a pharmaceutically acceptable carrier.

5. A diagnostic kit for the detection of White Spot Syndrome virus comprising the nucleic acid according to claim 1 .

Priority Claims (2)
EP 99202545 · Aug 3, 1999 · regional
EP 00200248 · Jan 24, 2000 · regional
Continuity (3)
Division 11737227 · Apr 19, 2007
Continuation 10048749
Related Publication 20100324125A1 · Dec 23, 2010